Kadant Solutions Introduces Ultimate Blade Line for High-Performance Doctoring
AUBURN, Mass., July 12, 2017 – Kadant Solutions, a division of Kadant Inc. (NYSE: KAI), announced the launch of its Ultimate Blade Line featuring nanotechnology-enhanced composite doctor blades. The proprietary doctor blade line incorporates nanotechnology-enhanced resins which are manipulated on a molecular scale to provide a composite resin matrix with increased resistance to chipping, improved inter-laminar bonding, and a lower coefficient of friction compared to conventional blades.
According to Steve Fielding, vice president, applications and technology, “The Ultimate Blade Line provides the papermaker with application-specific materials to enhance roll surface cleaning, sheet shedding, and significantly extend overall doctor blade life compared to conventional blades. The high-performance doctor blades result in fewer blade changes and the potential for reduced operating costs while enhancing overall doctoring and machine efficiency.”
Kadant Solutions, based in Auburn, Massachusetts, is a leading supplier of doctor blades, doctor blade holders, and doctoring systems for papermaking and other industrial processes. The Company’s cleaning and conditioning products are applied to the cleaning of forming and press fabrics and the filtration of process water as well as engineered wet-end products for papermaking.
Kadant Inc. is a global supplier of high-value, critical components and engineered systems used in process industries worldwide. The Company’s products, technologies, and services play an integral role in enhancing process efficiency, optimizing energy utilization, and maximizing productivity in resource-intensive industries. Kadant is based in Westford, Massachusetts, with approximately 2,300 employees in 20 countries worldwide. For more information, visit www.kadant.com.
The following constitutes a “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements that involve a number of risks and uncertainties, including forward-looking statements about our products and technologies. Our actual results may differ materially from these forward-looking statements as a result of various important factors, including those set forth under the heading "Risk Factors" in Kadant’s annual report on Form 10-K for the year ended December 31, 2016 and subsequent filings with the Securities and Exchange Commission. These include risks and uncertainties relating to adverse changes in global and local economic conditions; the variability and difficulty in accurately predicting revenues from large capital equipment and systems projects; the variability and uncertainties in sales of capital equipment in China; currency fluctuations; our customers’ ability to obtain financing for capital equipment projects; changes in government regulations and policies; oriented strand board market and levels of residential construction activity; development and use of digital media; price increases or shortages of raw materials; dependence on certain suppliers; international sales and operations; economic conditions and regulatory changes caused by the United Kingdom’s likely exit from the European Union; disruption in production; our acquisition strategy; our internal growth strategy; competition; soundness of suppliers and customers; our effective tax rate; future restructurings; soundness of financial institutions; our debt obligations; restrictions in our credit agreement; loss of key personnel; reliance on third-party research; protection of patents and proprietary rights; failure of our information systems or breaches of data security; fluctuations in our share price; and anti-takeover provisions. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.